The Discounted Cash Flow (DCF) valuation of ACRO Biomedical Co Ltd (ACBM) is (17.63) USD. With the latest stock price at 0.00 USD, the upside of ACRO Biomedical Co Ltd based on DCF is -2518849.4%.
Based on the latest price of 0.00 USD and our DCF valuation, ACRO Biomedical Co Ltd (ACBM) is a sell. selling ACBM stocks now will result in a potential gain of 2518849.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 5.3% | 5.1% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (83.74) - (10.11) | (17.63) |
| Upside | -11962918.9% - -1443677.7% | -2518849.4% |